Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on visible light catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111217766A reveals a visible-light promoted method for beta-amino selenide synthesis. Discover cost-effective, metal-free manufacturing advantages for pharmaceutical intermediates.
Patent CN118852253B reveals metal-free visible light catalysis for high-purity heterocyclic compounds offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN107417615A enables high-purity quinolinone manufacturing via visible light catalysis. Discover cost reduction and supply chain advantages for pharmaceutical intermediates.
Patent CN107417615A enables visible light promoted synthesis of chiral quinolinone derivatives. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN115232164B enables efficient sulfonyl thiophosphate production via visible light photocatalysis. Offers cost reduction and supply chain reliability for agrochemical intermediates.
Patent CN111848628A reveals a green g-C3N4 catalyzed route for high-purity intermediates, offering significant cost reduction and supply chain reliability for global API manufacturers.
Novel visible-light method using 4CzIPN for high-purity sulfone intermediates. Reduces cost and simplifies supply chain for pharma manufacturing.
Patent CN103467282A details a mild, iridium-catalyzed visible light method for synthesizing polysubstituted naphthols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112279754B reveals a mild blue-light photocatalytic route for fluorinated sesquiterpenes, offering cost-effective scaling for pharmaceutical intermediates.
Patent CN115043846B details a visible-light catalyzed route for pyrroloindole derivatives, offering scalable manufacturing and cost-effective pharmaceutical intermediate production.
Patent CN113292633B enables catalyst-free visible light hydrazine modification. Offers high purity unnatural amino acids with reduced manufacturing costs and scalable supply chain reliability.
Patent CN114835660A reveals a metal-free, visible-light mediated method for oxime ether synthesis, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114773284B details a visible light-mediated synthesis of dihydroisoxazoles using terminal olefins. Offers mild conditions and cost-effective raw materials for pharmaceutical intermediates.
Patent CN110759836B reveals a metal-free fluoroalkylation method using acetone and visible light, offering cost-effective synthesis for high-purity pharmaceutical intermediates.
Patent CN115108875A reveals a metal-free visible light asymmetric method for synthesizing nitrogen-containing chiral cyclic alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN113461617A reveals a metal-free visible light method for N-heterocycles. Offers cost reduction and high purity for pharmaceutical intermediate manufacturing supply chains.
Patent CN110981676A discloses a metal-free visible light method for beta-ketosulfones. Offers cost reduction and green manufacturing for pharmaceutical intermediates.
Novel metal-free decarboxylative ketonization method offers cost-effective, scalable production of high-purity pharmaceutical intermediates with green chemistry advantages.
Patent CN112390755B enables mild heteroarylation of amines using visible light. This breakthrough offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing globally.
Patent CN105130898A enables visible-light synthesis of gem-difluoro polycyclic compounds. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.